Komori
Mitsubishi Chemical Group (4188) · TargetAchieved

FY2022 consolidated earnings outlook

First written in FY2022. 2 of 4 entries say "Softened", first in FY2023-Q2. Latest entry: FY2023.

4entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022SoftenedFY2023-Q2 – FY2023-Q32022: 220222023: 22023
Same theme, other companies
Consolidated Earnings Forecasts for the Fiscal Year Ended March 2023A theme 25 companies write about · 4 as a headwind · 17 as a tailwind

7 other companies' latest entry also says "Achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 25 companies compared. The sentences above are computed from all 25.
Full recordFilings, disclosures and news, newest first
  1. FY2023AchievedAnnual report

    「Revenue was ¥4.6345 trillion, an increase of ¥657.6 billion from the previous consolidated fiscal year. Core operating profit was ¥325.6 billion, up ¥53.3 billion. Operating profit was ¥182.7 billion, down ¥120.5 billion, due to the recognition of impairment losses and other non-recurring items related to the Chemicals and Healthcare segments.」

    Actual FY2022 results exceeded the forecasts previously revised downward in the previous filing: revenue of ¥4.514 trillion, core operating profit of ¥200.0 billion, operating profit of ¥71.0 billion and profit attributable to owners of the parent of ¥28.0 billion.
  2. FY2023-Q3SoftenedAnnual report

    「Previously announced forecast (A) 47,250 2,400 2,420 1,700 1,320 92 84 Current revised forecast (B) 45,140 2,000 710 650 280 19 69 Change (B)−(A) △2,110 △400 △1,710 △1,050 △1,040 Change (%) △4.5 △16.7 △70.7 △61.8 △78.8」

    The earnings forecast for the current consolidated fiscal year was revised down as follows: revenue from ¥4.725 trillion to ¥4.514 trillion, core operating profit from ¥240.0 billion to ¥200.0 billion, operating profit from ¥242.0 billion to ¥71.0 billion, and profit attributable to owners of the parent from ¥132.0 billion to ¥28.0 billion. The reasons included weaker demand related to displays and softer market conditions and demand for MMA and petrochemicals, as well as losses associated with the end of production at the Kaçel plant and the liquidation of Medicago.
  3. FY2023-Q2SoftenedAnnual report

    「Current revised forecast (B) 47,250 2,400 2,420 1,700 1,320」

    For the FY2022 consolidated earnings forecast, revenue was raised from ¥4.436 trillion to ¥4.725 trillion, while core operating profit was revised down from ¥275.0 billion to ¥240.0 billion, operating profit from ¥277.0 billion to ¥242.0 billion, profit for the year from ¥194.0 billion to ¥170.0 billion, and profit attributable to owners of the parent from ¥153.0 billion to ¥132.0 billion.
  4. FY2022First statedAnnual report

    「Based on the foregoing, consolidated earnings for the following consolidated fiscal year are expected to be revenue of ¥4.436 trillion, core operating profit of ¥275.0 billion, operating profit of ¥277.0 billion, profit before tax of ¥266.0 billion, profit for the year of ¥194.0 billion and profit attributable to owners of the parent of ¥153.0 billion.」

    New numerical forecasts were presented for FY2022 revenue, core operating profit, operating profit, profit before tax, profit for the year and profit attributable to owners of the parent.
Moved together

"Arbitration over Gilenya royalties and revenue recognition risk" moved the same way as this thread, in the same document, in 3 of its 4 moves.

32★12
  1. ★This thread
  2. 1Arbitration over Gilenya royalties and revenue recognition risk3×
  3. 2Earnings volatility arising from demand, market conditions, raw material prices, foreign exchange and supply constraints2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Mitsubishi Chemical Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.